Cargando...

The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival

Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Commun Biol
Main Authors: Zhang, Jing, Caruso, Francesca P., Sa, Jason K., Justesen, Sune, Nam, Do-Hyun, Sims, Peter, Ceccarelli, Michele, Lasorella, Anna, Iavarone, Antonio
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478916/
https://ncbi.nlm.nih.gov/pubmed/31044160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0369-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!